Tronox price target lowered to $13 from $16 at Barclays
Barclays analyst Michael Leithead lowered the firm’s price target on Tronox (TROX) to $13 from $16 and keeps an Overweight rating on the ...
Cognex price target lowered to $37 from $43 at Truist
Truist lowered the firm’s price target on Cognex (CGNX) to $37 from $43 and keeps a Hold rating on the shares. The company’s Q4 results topped ...
Ultragenyx stock holds Buy rating, $140 target from Truist
Truist Securities maintained a positive outlook on Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), reiterating a Buy rating and a price target of $140. The firm's analyst highlighted the company's ...
Zacks.com on MSN4d
Wall Street Analysts Think Regenxbio (RGNX) Could Surge 333.01%: Read This Before Placing a Bet
Shares of Regenxbio (RGNX) have gained 9.3% over the past four weeks to close the last trading session at $8.21, but there could still be a solid upside left in the stock if short-term price targets ...